• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    AVEO Pharmaceuticals, Inc. (AVEO)

    -NasdaqGS
    1.92 0.00(0.00%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 18,123   1,293   19,286  
    Cost of Revenue -   -   -  
    Gross Profit 18,123   1,293   19,286  
    Operating Expenses
    Research Development38,254  68,468  91,358  
    Selling General and Administrative18,589  28,712  36,932  
    Non Recurring11,729  8,017  2,633  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (50,449) (103,904) (111,637)
    Income from Continuing Operations
    Total Other Income/Expenses Net98  2  744  
    Earnings Before Interest And Taxes(50,351)(103,902)(110,893)
    Interest Expense2,388  3,127  3,501  
    Income Before Tax(52,739)(107,029)(114,394)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(52,739)(107,029)(114,394)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (52,739) (107,029) (114,394)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (52,739) (107,029) (114,394)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.